PMV Pharmaceuticals Inc (PMVP)
1.81
+0.08
(+4.62%)
USD |
NASDAQ |
Apr 23, 16:00
1.81
0.00 (0.00%)
After-Hours: 17:39
PMV Pharmaceuticals Cash from Financing (TTM): 35.58M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 35.58M |
September 30, 2023 | 35.84M |
June 30, 2023 | 2.697M |
March 31, 2023 | 0.842M |
December 31, 2022 | 0.958M |
September 30, 2022 | 0.705M |
June 30, 2022 | 1.008M |
Date | Value |
---|---|
March 31, 2022 | 1.988M |
December 31, 2021 | 2.022M |
September 30, 2021 | 0.368M |
June 30, 2021 | 294.51M |
March 31, 2021 | 293.13M |
December 31, 2020 | 292.97M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.368M
Minimum
Sep 2021
294.51M
Maximum
Jun 2021
74.05M
Average
2.022M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
Exelixis Inc | -546.05M |
Geron Corp | 362.02M |
Verastem Inc | 134.19M |
Karyopharm Therapeutics Inc | 1.124M |
Kura Oncology Inc | 94.78M |